Local administration of chitosan microspheres after traumatic brain injury in rats: A new challenge for cyclosporine - A delivery

British Journal of Neurosurgery

Volumn 24, Issue 5, 2010, Pages 578-583

  Turkoglu, Omer Faruk ^a   Eroglu, Hakan ^b   Gurcan, Oktay ^c   Bodur, Ebru ^b   Sargon, Mustafa F ^b   Öner, Levent ^b   Beskonakli, Etem ^d  

^a ATATURK TRAINING AND RESEARCH HOSPITAL   (Turkey)

^b HACETTEPE UNIVERSITY   (Turkey)

^c Ankara Numune Training and Research Hospital   (Turkey)

^d Atatrk Training and Research Hospital   (Turkey)

Author keywords

chitosan; Cyclosporine A; microsphere; traumatic brain injury

Indexed keywords

CHITOSAN; CYCLOSPORIN A; METAL; MICROSPHERE; POLITEF;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN MITOCHONDRION; CONTROLLED STUDY; CRANIECTOMY; DRUG DELIVERY SYSTEM; DURA MATER; LIPID PEROXIDATION; MALE; NONHUMAN; PARIETAL LOBE; PRIORITY JOURNAL; RAT; SHAM PROCEDURE; TRAUMATIC BRAIN INJURY; ULTRASTRUCTURE;

ANIMALS; BRAIN INJURIES; CHITOSAN; CYCLOSPORINE; DISEASE MODELS, ANIMAL; MALE; MICROSPHERES; MITOCHONDRIA; RATS; RATS, SPRAGUE-DAWLEY;

EID: 77957312349     PISSN: 02688697     EISSN: 1360046X     Source Type: Journal    
DOI: 10.3109/02688697.2010.487126     Document Type: Article

References (40)

1. Hall ED, Kupina NC, Althaus JS. Peroxynitrite scavengers for the acute treatment of traumatic brain injury. Ann NY Acad Sci 1999;890:462-8.
2. Lifshitz J, Friberg H, Neumar RW, et al. Structural and functional damage sustained by mitochondria after traumatic brain injury in the rat: evidence for differentially sensitive populations in the cortex and hippocampus. J Cereb Blood Flow Metab 2003;23(2):219-31.
3. Tsubokawa T, Jadhav V, Solaroglu I, et al. Lecithinized superoxide dismutase improves outcomes and attenuates focal cerebral ischemic injury via antiapoptotic mechanisms in rats. Stroke 2007;38(3):1057-62.
4. Diaz-Ruiz A, Rios C, Duarte I, et al. Cyclosporin-A inhibits lipid peroxidation after spinal cord injury in rats. Neurosci Lett 1999;266(1):61-4.
5. Riess P, Bareyre FM, Saatman KE, et al. Effects of chronic, post-injury cyclosporin A administration on motor and sensorimotor function following severe, experimental traumatic brain injury. Restor Neurol Neurosci 2001;18(1):1-8.
6. Sullivan PG, Rabchevsky AG, Hicks RR, et al. Dose-response curve and optimal dosing regimen of cyclosporin A after traumatic brain injury in rats. Neuroscience 2000;101(2):289-95.
7. Royo NC, Shimizu S, Schouten JW, Stover JF, McIntosh TK. Pharmacology of traumatic brain injury. Curr Opin Pharmacol 2003;3:27-32.
8. Kas HS. Chitosan: properties, preparations and application to microparticulate systems. J Microencapsul 1997;14(6):689-711.
9. Niu X, Feng Q, Wang M, Guo X, Zheng Q. Porous nano-HA/collagen/PLLA scaffold containing chitosan microspheres for controlled delivery of synthetic peptide derived from BMP-2. J Control Release, 2009:134 (2):111-7.
10. Wang AH, Chen XG, Liu CS, et al. Preparation and characteristics of chitosan microspheres in different acetylation as drug carrier system. J Microencapsul 2008;24:1-10.
11. Sullivan PG, Thompson MB, Scheff SW. Cyclosporin A attenuates acute mitochondrial dysfunction following traumatic brain injury. Exp Neurol 1999;160(1):226-34.
12. Povlishock JT, Pettus EH. Traumatically induced axonal damage: evidence for enduring changes in axolemmal permeability with associated cytoskeletal change. Acta Neurochir Suppl 1996;66:81-6.
13. Okonkwo DO, Povlishock JT. An intrathecal bolus of cyclosporin A before injury preserves mitochondrial integrity and attenuates axonal disruption in traumatic brain injury. J Cereb Blood Flow Metab 1999;19(4):443-51.
14. Okonkwo DO, Melon DE, Pellicane AJ, et al. Dose-response of cyclosporin A in attenuating traumatic axonal injury in rat. Neuroreport 2003;14(3):463-6.
15. Signoretti S, Marmarou A, Tavazzi B, et al. The protective effect of cyclosporin A upon N-acetylaspartate and mitochondrial dysfunction following experimental diffuse traumatic brain injury. J Neurotrauma 2004;21(9):1154-67.
16. Bejugam NK, Uddin AN, Gayakwad SG, D'Souza MJ. Formulation and evaluation of albumin microspheres and its enteric coating using a spray-dryer. J Microencapsul 2008;25(8):577-83.
17. Siwale RC, Oettinger CW, Balakrishna Pai S, et al. Formulation and characterization of catalase in albumin microspheres. J Microencapsul 2009;26(5):411-19.
18. Sun Y, Cui F, Shi K, et al. The effect of chitosan molecular weight on the characteristics of spray-dried methotrexateloaded chitosan microspheres for nasal administration. Drug Dev Ind Pharm 2009;35(3):379-86.
19. Solaroglu I, Okutan O, Kaptanoglu E, Beskonakli E, Kilinc K. Increased xanthine oxidase activity after traumatic brain injury in rats. J Clin Neurosci 2005;12(3):273-5.
20. Feeney DM, Boyeson MG, Linn RT, Murray HM, Dail WG. Responses to cortical injury: I. Methodology and local effects of contusions in the rat. Brain Res 1981;211(1):67-77.
21. Murakami K, Kondo T, Yang G, et al. Cold injury in mice: a model to study mechanisms of brain edema and neuronal apoptosis. Prog Neurobiol 1999;57(3):289-99.
22. Ohkawa H, Ohishi N, Yagi K. Assay for lipid peroxides in animal tissues by thiobarbituric acid reaction. Anal Biochem 1979;95(2):351-8.
23. Yildirim E, Solaroglu I, Okutan O, et al. Ultrastructural changes in tracheobronchial epithelia following experimental traumatic brain injury in rats: protective effect of erythropoietin. J Heart Lung Transplant 2004;23(12):1423-9.
24. Ozisik K, Yildirim E, Kaplan S, et al. Ultrastructural changes of rat cardiac myocytes in a time-dependent manner after traumatic brain injury. Am J Transplant 2004;4(6):900-4.
25. Mazzeo AT, Alves OL, Gilman CB, et al. Brain metabolic and hemodynamic effects of cyclosporin A after human severe traumatic brain injury: a microdialysis study. Acta Neurochir (Wien) 2008;150(10):1019-31; discussion 1031.
26. Petit PX, Zamzami N, Vayssiere JL, et al. Implication of mitochondria in apoptosis. Mol Cell Biochem 1997;174(1-2): 185-8.
27. Okonkwo DO, Buki A, Siman R, Povlishock JT. Cyclosporin A limits calcium-induced axonal damage following traumatic brain injury. Neuroreport 1999;10(2):353-8.
28. Ankarcrona M, Dypbukt JM, Bonfoco E, et al. Glutamateinduced neuronal death: a succession of necrosis or apoptosis depending on mitochondrial function. Neuron 1995;15(4):961-73.
29. Zoratti M, Szabo I. The mitochondrial permeability transition. Biochim Biophys Acta 1995;1241(2):139-76.
30. 2 (+)-induced large-amplitude swelling of liver and heart mitochondria by cyclosporin is probably caused by the inhibitor binding to mitochondrial-matrix peptidyl-prolyl cis-trans isomerase and preventing it interacting with the adenine nucleotide translocase. Biochem J 1990;268(1):153-60.
31. Nicholls DG, Budd SL. Mitochondria and neuronal glutamate excitotoxicity. Biochim Biophys Acta 1998;1366(1-2): 97-112.
32. Scheff SW, Sullivan PG. Cyclosporin A significantly ameliorates cortical damage following experimental traumatic brain injury in rodents. J Neurotrauma 1999;16(9):783-92.
33. Solaroglu I, Okutan O, Solaroglu A, et al. Maternal treatment with propofol attenuates lipid peroxidation after transient intrauterine ischemia in the neonatal rat brain. Biol Neonate 2004;85(4):221-4.
34. Schinder AF, Olson EC, Spitzer NC, Montal M. Mitochondrial dysfunction is a primary event in glutamate neurotoxicity. J Neurosci 1996;16(19):6125-33.
35. Ibarra A, Diaz-Ruiz A. Protective effect of cyclosporin-A in spinal cord injury: an overview. Curr Med Chem 2006;13(22):2703-10.
36. Kahan BD. Cyclosporine. N Engl J Med 1989;321(25):1725-38.
37. Hughes RL. Cyclosporine-related central nervous system toxicity in cardiac transplantation. N Engl J Med 1990;323(6):420-1.
38. Reece DE, Frei-Lahr DA, Shepherd JD, et al. Neurologic complications in allogeneic bone marrow transplant patients receiving cyclosporin. Bone Marrow Transplant 1991;8(5):393-401.
39. Almond BA, Hadba AR, Freeman ST, et al. Efficacy of mitoxantrone-loaded albumin microspheres for intratumoral chemotherapy of breast cancer. J Control Release 2003;91(1-2): 147-55.
40. Jameela SR, Latha PG, Subramoniam A, Jayakrishnan A. Antitumour activity of mitoxantrone-loaded chitosan microspheres against Ehrlich ascites carcinoma. J Pharm Pharmacol 1996;48(7):685-8.